Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: Its incidence and characteristics of action

K. Arikawa, Y. Ichikawa, Tadashi Yoshida, T. Shinozawa, M. Homma, N. Momotani, K. Ito

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The incidence, characteristics of action, and pathogenetic importance of blocking type anti-TSH receptor antibody were examined in patients with autoimmune thyroid chronic thyroiditis. Serum immunoglobulin G (IgG) from 8 of 20 patients with nongoitrous hypothyroidism contained substantial amounts of TSH binding inhibitor immunoglobulin (TBII) activity. Newborn infants of a patient with the greatest TBII activity had neonatal transient hypothyroidism. In sera of patients with goitrous hypothyroidism and euthyroiditis, only weakly positive or negative TBII activity was found. IgGs of these patients and those of nongoitrous hypothyroid patients without strongly positive TBII activity did not inhibit TSH stimulation of thyroid adenylate cyclase activity. Seven of 8 IgGs which had strongly positive TBII activity significantly inhibited cAMP generation induced by 9.1 mU/ml TSH, and the eighth IgG inhibited stimulation with 0.5 mU/ml TSH. Although the modes of TSH binding inhibition were variable, markedly close correlation was found between TSH binding- and TSH stimulation-inhibiting activities of these 8 IgGs (r = 0.90; P < 0.01). These IgGs may exert their inhibitory effects on adenylate cyclase activity by inhibiting TSH binding to its receptor.

Original languageEnglish
Pages (from-to)953-959
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume60
Issue number5
Publication statusPublished - 1985
Externally publishedYes

Fingerprint

Hypothyroidism
Immunoglobulins
Antibodies
Incidence
Adenylyl Cyclases
Immunoglobulin G
Thyroid Gland
Serum
Newborn Infant

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism : Its incidence and characteristics of action. / Arikawa, K.; Ichikawa, Y.; Yoshida, Tadashi; Shinozawa, T.; Homma, M.; Momotani, N.; Ito, K.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 60, No. 5, 1985, p. 953-959.

Research output: Contribution to journalArticle

@article{14b47116c8a84fffb221e24e9f1187dc,
title = "Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: Its incidence and characteristics of action",
abstract = "The incidence, characteristics of action, and pathogenetic importance of blocking type anti-TSH receptor antibody were examined in patients with autoimmune thyroid chronic thyroiditis. Serum immunoglobulin G (IgG) from 8 of 20 patients with nongoitrous hypothyroidism contained substantial amounts of TSH binding inhibitor immunoglobulin (TBII) activity. Newborn infants of a patient with the greatest TBII activity had neonatal transient hypothyroidism. In sera of patients with goitrous hypothyroidism and euthyroiditis, only weakly positive or negative TBII activity was found. IgGs of these patients and those of nongoitrous hypothyroid patients without strongly positive TBII activity did not inhibit TSH stimulation of thyroid adenylate cyclase activity. Seven of 8 IgGs which had strongly positive TBII activity significantly inhibited cAMP generation induced by 9.1 mU/ml TSH, and the eighth IgG inhibited stimulation with 0.5 mU/ml TSH. Although the modes of TSH binding inhibition were variable, markedly close correlation was found between TSH binding- and TSH stimulation-inhibiting activities of these 8 IgGs (r = 0.90; P < 0.01). These IgGs may exert their inhibitory effects on adenylate cyclase activity by inhibiting TSH binding to its receptor.",
author = "K. Arikawa and Y. Ichikawa and Tadashi Yoshida and T. Shinozawa and M. Homma and N. Momotani and K. Ito",
year = "1985",
language = "English",
volume = "60",
pages = "953--959",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism

T2 - Its incidence and characteristics of action

AU - Arikawa, K.

AU - Ichikawa, Y.

AU - Yoshida, Tadashi

AU - Shinozawa, T.

AU - Homma, M.

AU - Momotani, N.

AU - Ito, K.

PY - 1985

Y1 - 1985

N2 - The incidence, characteristics of action, and pathogenetic importance of blocking type anti-TSH receptor antibody were examined in patients with autoimmune thyroid chronic thyroiditis. Serum immunoglobulin G (IgG) from 8 of 20 patients with nongoitrous hypothyroidism contained substantial amounts of TSH binding inhibitor immunoglobulin (TBII) activity. Newborn infants of a patient with the greatest TBII activity had neonatal transient hypothyroidism. In sera of patients with goitrous hypothyroidism and euthyroiditis, only weakly positive or negative TBII activity was found. IgGs of these patients and those of nongoitrous hypothyroid patients without strongly positive TBII activity did not inhibit TSH stimulation of thyroid adenylate cyclase activity. Seven of 8 IgGs which had strongly positive TBII activity significantly inhibited cAMP generation induced by 9.1 mU/ml TSH, and the eighth IgG inhibited stimulation with 0.5 mU/ml TSH. Although the modes of TSH binding inhibition were variable, markedly close correlation was found between TSH binding- and TSH stimulation-inhibiting activities of these 8 IgGs (r = 0.90; P < 0.01). These IgGs may exert their inhibitory effects on adenylate cyclase activity by inhibiting TSH binding to its receptor.

AB - The incidence, characteristics of action, and pathogenetic importance of blocking type anti-TSH receptor antibody were examined in patients with autoimmune thyroid chronic thyroiditis. Serum immunoglobulin G (IgG) from 8 of 20 patients with nongoitrous hypothyroidism contained substantial amounts of TSH binding inhibitor immunoglobulin (TBII) activity. Newborn infants of a patient with the greatest TBII activity had neonatal transient hypothyroidism. In sera of patients with goitrous hypothyroidism and euthyroiditis, only weakly positive or negative TBII activity was found. IgGs of these patients and those of nongoitrous hypothyroid patients without strongly positive TBII activity did not inhibit TSH stimulation of thyroid adenylate cyclase activity. Seven of 8 IgGs which had strongly positive TBII activity significantly inhibited cAMP generation induced by 9.1 mU/ml TSH, and the eighth IgG inhibited stimulation with 0.5 mU/ml TSH. Although the modes of TSH binding inhibition were variable, markedly close correlation was found between TSH binding- and TSH stimulation-inhibiting activities of these 8 IgGs (r = 0.90; P < 0.01). These IgGs may exert their inhibitory effects on adenylate cyclase activity by inhibiting TSH binding to its receptor.

UR - http://www.scopus.com/inward/record.url?scp=0021840453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021840453&partnerID=8YFLogxK

M3 - Article

C2 - 2858492

AN - SCOPUS:0021840453

VL - 60

SP - 953

EP - 959

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -